Levine Cancer Institute, Atrium Health — Charlotte, North Carolina

Public research footprint of Levine Cancer Institute, Atrium Health, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Lymphoma, B-Cell · Coronavirus Infection · Locally Advanced Pancreatic Cancer · Chronic Lymphocytic Leukemia

Recently updated registry entries

NCT03917381 — GEN1046 Safety Trial in Patients With Malignant Solid Tumors (Active Not Recruiting)
NCT07428538 — Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With… (Recruiting)
NCT06792734 — Phase 1 Trial of BTM-3566 in Relapsed/Refractory Mature B Cell Lymphomas (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Levine Cancer Institute, Atrium Health?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.